These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 10708284

  • 1. Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.
    Grabar S, Pradier C, Le Corfec E, Lancar R, Allavena C, Bentata M, Berlureau P, Dupont C, Fabbro-Peray P, Poizot-Martin I, Costagliola D.
    AIDS; 2000 Jan 28; 14(2):141-9. PubMed ID: 10708284
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir.
    Kirk O, Mocroft A, Pradier C, Bruun JN, Hemmer R, Clotet B, Miller V, Viard JP, Phillips AN, Lundgren JD, EuroSIDA Study Group.
    AIDS; 2001 May 25; 15(8):999-1008. PubMed ID: 11399982
    [Abstract] [Full Text] [Related]

  • 3. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients.
    Fätkenheuer G, Theisen A, Rockstroh J, Grabow T, Wicke C, Becker K, Wieland U, Pfister H, Reiser M, Hegener P, Franzen C, Schwenk A, Salzberger B.
    AIDS; 1997 Nov 15; 11(14):F113-6. PubMed ID: 9386799
    [Abstract] [Full Text] [Related]

  • 4. Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients.
    Casado JL, Perez-Elías MJ, Antela A, Sabido R, Martí-Belda P, Dronda F, Blazquez J, Quereda C.
    AIDS; 1998 Jul 30; 12(11):F131-5. PubMed ID: 9708403
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection.
    d'Arminio Monforte A, Testa L, Adorni F, Chiesa E, Bini T, Moscatelli GC, Abeli C, Rusconi S, Sollima S, Balotta C, Musicco M, Galli M, Moroni M.
    AIDS; 1998 Sep 10; 12(13):1631-7. PubMed ID: 9764782
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.
    Figgitt DP, Plosker GL.
    Drugs; 2000 Aug 10; 60(2):481-516. PubMed ID: 10983742
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy.
    Piketty C, Race E, Castiel P, Belec L, Peytavin G, Si-Mohamed A, Gonzalez-Canali G, Weiss L, Clavel F, Kazatchkine MD.
    AIDS; 1999 Jul 30; 13(11):F71-7. PubMed ID: 10449277
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D, Ledergerber B, Weber R, Jost J, Flepp M, Opravil M, Ruef C, Zimmerli S.
    AIDS Res Hum Retroviruses; 1999 Dec 10; 15(18):1631-8. PubMed ID: 10606086
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Long-term immunologic response in HIV-infected patients with CD4 cell counts </= 50/mm3 when initiating protease inhibitor therapy].
    Le Moing V, Eid Z, Ecobichon JL, Duval X, Longuet P, Elbim C, Brun-Vezinet F, Leport C, Vilde JL.
    Ann Med Interne (Paris); 2001 Feb 10; 152(1):11-4. PubMed ID: 11240420
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Chêne G, Binquet C, Moreau JF, Neau D, Pellegrin I, Malvy D, Ceccaldi J, Lacoste D, Dabis F.
    AIDS; 1998 Dec 03; 12(17):2313-20. PubMed ID: 9863874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.